BACKGROUND: Since the identification of xenotropic murine leukemia virus-related virus (XMRV) in prostate cancer patients in 2006 and in chronic fatigue syndrome patients in 2009, conflicting findings have been reported regarding its etiologic role in human diseases and prevalence in general populations. In this study, we screened both plasma and peripheral blood mononuclear cells (PBMNCs) collected in Africa from blood donors and human immunodeficiency virus Type 1 (HIV-1)-infected individuals to gain evidence of XMRV infection in this geographic region. STUDY DESIGN AND METHODS: A total of 199 plasma samples, 19 PBMNC samples, and 50 culture supernatants from PBMNCs of blood donors from Cameroon found to be infected with HIV-1 and HIV-1 patients from Uganda were screened for XMRV infection using a sensitive nested polymerase chain reaction (PCR) or reverse transcription (RT)-PCR assay. RESULTS: Using highly sensitive nested PCR or RT-PCR and real-time PCR assays capable of detecting at least 10 copies of XMRV plasmid DNA per reaction, none of the 268 samples tested were found to be XMRV DNA or RNA positive. CONCLUSIONS: Our results failed to demonstrate the presence of XMRV infection in African blood donors or individuals infected with HIV-1. More studies are needed to understand the prevalence, epidemiology, and geographic distribution of XMRV infection worldwide.
BACKGROUND: Since the identification of xenotropic murine leukemia virus-related virus (XMRV) in prostate cancerpatients in 2006 and in chronic fatigue syndromepatients in 2009, conflicting findings have been reported regarding its etiologic role in human diseases and prevalence in general populations. In this study, we screened both plasma and peripheral blood mononuclear cells (PBMNCs) collected in Africa from blood donors and humanimmunodeficiency virus Type 1 (HIV-1)-infected individuals to gain evidence of XMRV infection in this geographic region. STUDY DESIGN AND METHODS: A total of 199 plasma samples, 19 PBMNC samples, and 50 culture supernatants from PBMNCs of blood donors from Cameroon found to be infected with HIV-1 and HIV-1patients from Uganda were screened for XMRV infection using a sensitive nested polymerase chain reaction (PCR) or reverse transcription (RT)-PCR assay. RESULTS: Using highly sensitive nested PCR or RT-PCR and real-time PCR assays capable of detecting at least 10 copies of XMRV plasmid DNA per reaction, none of the 268 samples tested were found to be XMRV DNA or RNA positive. CONCLUSIONS: Our results failed to demonstrate the presence of XMRV infection in African blood donors or individuals infected with HIV-1. More studies are needed to understand the prevalence, epidemiology, and geographic distribution of XMRV infection worldwide.
Authors: C Yang; D Pieniazek; S M Owen; C Fridlund; J Nkengasong; T D Mastro; M A Rayfield; R Downing; B Biryawaho; A Tanuri; L Zekeng; G van der Groen; F Gao; R B Lal Journal: J Clin Microbiol Date: 1999-08 Impact factor: 5.948
Authors: William M Switzer; Hongwei Jia; Oliver Hohn; HaoQiang Zheng; Shaohua Tang; Anupama Shankar; Norbert Bannert; Graham Simmons; R Michael Hendry; Virginia R Falkenberg; William C Reeves; Walid Heneine Journal: Retrovirology Date: 2010-07-01 Impact factor: 4.602
Authors: Emily C Knouf; Michael J Metzger; Patrick S Mitchell; Jason D Arroyo; John R Chevillet; Muneesh Tewari; A Dusty Miller Journal: J Virol Date: 2009-04-29 Impact factor: 5.103
Authors: Seunghee Hong; Eric A Klein; Jaydip Das Gupta; Kirsten Hanke; Christopher J Weight; Carvell Nguyen; Christina Gaughan; Kyeong-Ae Kim; Norbert Bannert; Frank Kirchhoff; Jan Munch; Robert H Silverman Journal: J Virol Date: 2009-04-29 Impact factor: 5.103
Authors: Vincent C Lombardi; Francis W Ruscetti; Jaydip Das Gupta; Max A Pfost; Kathryn S Hagen; Daniel L Peterson; Sandra K Ruscetti; Rachel K Bagni; Cari Petrow-Sadowski; Bert Gold; Michael Dean; Robert H Silverman; Judy A Mikovits Journal: Science Date: 2009-10-08 Impact factor: 47.728
Authors: Robert Schlaberg; Daniel J Choe; Kristy R Brown; Harshwardhan M Thaker; Ila R Singh Journal: Proc Natl Acad Sci U S A Date: 2009-09-08 Impact factor: 11.205
Authors: Anatoly Urisman; Ross J Molinaro; Nicole Fischer; Sarah J Plummer; Graham Casey; Eric A Klein; Krishnamurthy Malathi; Cristina Magi-Galluzzi; Raymond R Tubbs; Don Ganem; Robert H Silverman; Joseph L DeRisi Journal: PLoS Pathog Date: 2006-03-31 Impact factor: 6.823
Authors: Oliver Hohn; Hans Krause; Pia Barbarotto; Lars Niederstadt; Nadine Beimforde; Joachim Denner; Kurt Miller; Reinhard Kurth; Norbert Bannert Journal: Retrovirology Date: 2009-10-16 Impact factor: 4.602
Authors: Graham Simmons; Simone A Glynn; Anthony L Komaroff; Judy A Mikovits; Leslie H Tobler; John Hackett; Ning Tang; William M Switzer; Walid Heneine; Indira K Hewlett; Jiangqin Zhao; Shyh-Ching Lo; Harvey J Alter; Jeffrey M Linnen; Kui Gao; John M Coffin; Mary F Kearney; Francis W Ruscetti; Max A Pfost; James Bethel; Steven Kleinman; Jerry A Holmberg; Michael P Busch Journal: Science Date: 2011-09-22 Impact factor: 47.728
Authors: Ning Tang; Andrea Frank; Gregor Leckie; John Hackett; Graham Simmons; Michael Busch; Klara Abravaya Journal: J Virol Methods Date: 2011-10-25 Impact factor: 2.014
Authors: Graham Simmons; Simone A Glynn; Jerry A Holmberg; John M Coffin; Indira K Hewlett; Shyh-Ching Lo; Judy A Mikovits; William M Switzer; Jeffrey M Linnen; Michael P Busch Journal: Transfusion Date: 2011-03-01 Impact factor: 3.157
Authors: Gregory Q Del Prete; Mary F Kearney; Jon Spindler; Ann Wiegand; Elena Chertova; James D Roser; Jacob D Estes; Xing Pei Hao; Charles M Trubey; Abigail Lara; Kyeongeun Lee; Chawaree Chaipan; Julian W Bess; Kunio Nagashima; Brandon F Keele; Rhonda Macallister; Jeremy Smedley; Vinay K Pathak; Vineet N Kewalramani; John M Coffin; Jeffrey D Lifson Journal: J Virol Date: 2012-01-11 Impact factor: 5.103